相关实验视频
Updated: Jun 24, 2025
19:50
Interview: Protein Folding and Studies of Neurodegenerative Diseases
Published on: July 16, 2008
12.9K
了解AlphaFold在神经退行性疾病方面的突破
Hira Mubeen1, Ammara Masood2, Asma Zafar2
1Department of Biotechnology, Faculty of Science & Technology, University of Central Punjab, Lahore, Pakistan. hira.mubeen@ucp.edu.pk.
Irish journal of medical science
|June 4, 2024
概括
人工智能和深度学习,特别是AlphaFold,通过预测蛋白质结构来了解神经退行性疾病 (NDs) 的前景. 这有助于识别疾病机制和中枢神经系统疾病的潜在治疗点.
科学领域:
- 神经科学是一个神经科学.
- 计算生物学 计算生物学
- 人工智能的人工智能
背景情况:
- 神经退行性疾病 (NDs) 涉及神经元功能障碍和损失,影响认知和运动功能.
- 常见的ND包括阿尔茨海默氏病 (AD) 和帕金森病 (PD),其特点是蛋白质病变,如粉样蛋白β,形病变和同核病变.
- 蛋白质错误折叠和聚合是NDs的关键病理特征.
研究的目的:
- 探索人工智能 (AI) 和深度学习 (DL) 在诊断和治疗神经退行性疾病中的应用.
- 突出像AlphaFold (AF) 这样的DL模型在促进对中枢神经系统疾病的理解方面的潜力.
主要方法:
- 使用深度学习方法,特别是AlphaFold,用于3D蛋白质几何建模.
- 利用人工智能以高准确度预测蛋白质确认和相互作用.
主要成果:
- AlphaFold在预测3D蛋白质结构方面表现出显著的潜力,与实验方法相比.
- 这种能力可以帮助识别疾病的进展和理解NDs中的信号通路干扰.
- AlphaFold的预测能力为研究与疾病相关的蛋白质相互作用提供了优势.
结论:
- AI和DL,以AlphaFold为例,代表了神经退行性疾病研究的重大进展.
- 这些技术可以彻底改变对中枢神经系统疾病中蛋白质结构和功能的研究.
- 需要进一步开发,因为AlphaFold目前无法预测膜蛋白,这对于药物设计至关重要.
相关概念视频
03:03Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
01:26Alzheimer's Disease: Overview
462
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
462
01:22Alzheimer's Disease: Treatment
179
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
179